Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanta Subbarao

Showing results (101-110 of 300) with videos related to

Pageof 30
Sort By:
Vaccine|June 28, 2008
FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007Maryna Eichelberger, Hana Golding, Maureen Hess, et al.
Medrxiv : the Preprint Server for Health Sciences|July 23, 2024
Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccinesDavid Hodgson, Yi Liu, Louise Carolan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2004
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes miceHimani Bisht, Anjeanette Roberts, Leatrice Vogel, et al.
Nature|April 2, 2004
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in miceZhi-Yong Yang, Wing-Pui Kong, Yue Huang, et al.
The Journal of Infectious Diseases|December 15, 2015
Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)Mahdee Sobhanie, Yumiko Matsuoka, Sinthujan Jegaskanda, et al.
Journal of Virology|April 24, 2015
A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and FerretsMariana Baz, Myeisha Paskel, Yumiko Matsuoka, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2004
Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunityUrsula J Buchholz, Alexander Bukreyev, Lijuan Yang, et al.
Journal of Virology|July 19, 2013
Mammalian adaptation in the PB2 gene of avian H5N1 influenza virusJi-Young Min, Celia Santos, Adam Fitch, et al.
Vaccine|December 3, 2014
Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primatesAndrew J Broadbent, Celia P Santos, Myeisha Paskel, et al.
The Journal of Hospital Infection|July 2, 2025
Modelling the joint effects of single occupancy and N95 respirators on COVID-19 outbreaks in hospital wardsCameron Zachreson, Robyn Schofield, Caroline Marshall, et al.
Pageof 30

Showing results (101-110 of 300) with videos related to

Sort By:
Pageof 30
Vaccine|June 28, 2008
FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007Maryna Eichelberger, Hana Golding, Maureen Hess, et al.
Medrxiv : the Preprint Server for Health Sciences|July 23, 2024
Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccinesDavid Hodgson, Yi Liu, Louise Carolan, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2004
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes miceHimani Bisht, Anjeanette Roberts, Leatrice Vogel, et al.
Nature|April 2, 2004
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in miceZhi-Yong Yang, Wing-Pui Kong, Yue Huang, et al.
The Journal of Infectious Diseases|December 15, 2015
Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)Mahdee Sobhanie, Yumiko Matsuoka, Sinthujan Jegaskanda, et al.
Journal of Virology|April 24, 2015
A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and FerretsMariana Baz, Myeisha Paskel, Yumiko Matsuoka, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2004
Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunityUrsula J Buchholz, Alexander Bukreyev, Lijuan Yang, et al.
Journal of Virology|July 19, 2013
Mammalian adaptation in the PB2 gene of avian H5N1 influenza virusJi-Young Min, Celia Santos, Adam Fitch, et al.
Vaccine|December 3, 2014
Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primatesAndrew J Broadbent, Celia P Santos, Myeisha Paskel, et al.
The Journal of Hospital Infection|July 2, 2025
Modelling the joint effects of single occupancy and N95 respirators on COVID-19 outbreaks in hospital wardsCameron Zachreson, Robyn Schofield, Caroline Marshall, et al.
Pageof 30